Man Group’s Verona Pharma VRNA Stock Holding History

Man Group’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-415,732	Closed	-$44.4M	–	2490
2025 Q3	$44.4M	Buy	+415,732	New	+$43.4M	0.08%	290

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Man Group's VRNA Position: Q4 2025 in Review

Man Group sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 415,732 shares — an estimated $44.4M sold.

Man Group first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $44.4M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Man Group reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Man Group sold 415,732 Verona Pharma shares in Q4 2025, an estimated $44.4M.
Man Group first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Man Group's Verona Pharma position peaked at $44.4M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Man Group's 13F filing for Q4 2025, filed 17 Feb 2026.